# TINY CARGO COMPANY, THE: XoLacta: An Adjuvant Therapy for treatment of Radiation Side effects during HER2-Positive Breast Cancer Treatment

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | TINY CARGO COMPANY, THE |
| Location | ROANOKE, VA |
| Project | XoLacta: An Adjuvant Therapy for treatment of Radiation Side effects during HER2-Positive Breast Cancer Treatment |
| Project number | 5R44CA272078-03 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $1,022,907 |
| Awarded | 2026-09-08 |
| Project period | 2023-09-22 to 2027-08-31 |
| UEI | V4VBSJU5L458 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11413717). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.